ArticleCancers2026

Artificial Intelligence-Assisted Prediction of Immunotherapy Benefit and Recurrence Risk Stratification in Gastric Cancer: A Single-Center Real-World Study.

Dou-Dou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.